These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

648 related items for PubMed ID: 30541458

  • 1. Exclusive enteral nutrition with concomitant early thiopurine use was effective in maintaining steroid-free remission in a Southeast Asian cohort of children with Crohn's disease.
    Ong C, Lim PT, Logarajah V, Liwanag MJ, Ang BX, Cher Y, Chiou FK, Kader A.
    BMC Gastroenterol; 2018 Dec 12; 18(1):185. PubMed ID: 30541458
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Repeated exclusive enteral nutrition in the treatment of paediatric Crohn's disease: predictors of efficacy and outcome.
    Frivolt K, Schwerd T, Werkstetter KJ, Schwarzer A, Schatz SB, Bufler P, Koletzko S.
    Aliment Pharmacol Ther; 2014 Jun 12; 39(12):1398-407. PubMed ID: 24779671
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Time to Relapse in Children with Crohn's Disease Treated with Azathioprine and Nutritional Therapy or Corticosteroids.
    Hradsky O, Copova I, Zarubova K, Nevoral J, Bronsky J.
    Dig Dis Sci; 2016 Jul 12; 61(7):2041-50. PubMed ID: 26971092
    [Abstract] [Full Text] [Related]

  • 6. Evaluation of exclusive enteral nutrition and corticosteroid induction treatment in new-onset moderate-to-severe luminal paediatric Crohn's disease.
    Jongsma MME, Vuijk SA, Cozijnsen MA, van Pieterson M, Norbruis OF, Groeneweg M, Wolters VM, van Wering HM, Hojsak I, Kolho KL, van Wijk MP, Teklenburg-Roord STA, de Meij TGJ, Escher JC, de Ridder L.
    Eur J Pediatr; 2022 Aug 12; 181(8):3055-3065. PubMed ID: 35672586
    [Abstract] [Full Text] [Related]

  • 7. Use of exclusive enteral nutrition in paediatric Crohn's disease in The Netherlands.
    de Bie C, Kindermann A, Escher J.
    J Crohns Colitis; 2013 May 12; 7(4):263-70. PubMed ID: 22820027
    [Abstract] [Full Text] [Related]

  • 8. Tolerance and efficacy of azathioprine in pediatric Crohn's disease.
    Riello L, Talbotec C, Garnier-Lengliné H, Pigneur B, Svahn J, Canioni D, Goulet O, Schmitz J, Ruemmele FM.
    Inflamm Bowel Dis; 2011 Oct 12; 17(10):2138-43. PubMed ID: 21910176
    [Abstract] [Full Text] [Related]

  • 9. [Exclusive enteral nutrition continues to be first line therapy for pediatric Crohn's disease in the era of biologics].
    Navas-López VM, Blasco-Alonso J, Lacasa Maseri S, Girón Fernández-Crehuet F, Serrano Nieto MJ, Vicioso Recio MI, Sierra Salinas C.
    An Pediatr (Barc); 2015 Jul 12; 83(1):47-54. PubMed ID: 24704330
    [Abstract] [Full Text] [Related]

  • 10. A retrospective study showing maintenance treatment options for paediatric CD in the first year following diagnosis after induction of remission with EEN: supplemental enteral nutrition is better than nothing!
    Duncan H, Buchanan E, Cardigan T, Garrick V, Curtis L, McGrogan P, Barclay A, Russell RK.
    BMC Gastroenterol; 2014 Mar 20; 14():50. PubMed ID: 24645851
    [Abstract] [Full Text] [Related]

  • 11. Partial enteral nutrition induces clinical and endoscopic remission in active pediatric Crohn's disease: results of a prospective cohort study.
    Urlep D, Benedik E, Brecelj J, Orel R.
    Eur J Pediatr; 2020 Mar 20; 179(3):431-438. PubMed ID: 31781933
    [Abstract] [Full Text] [Related]

  • 12. [Effectiveness of induction therapy with exclusive enteral nutrition in pediatric Crohn's disease].
    Luo YY, Fang YH, Yu JD, Xu LJ, Sun MF, Cheng Q, Chen J.
    Zhongguo Dang Dai Er Ke Za Zhi; 2022 Jun 15; 24(6):626-630. PubMed ID: 35762427
    [Abstract] [Full Text] [Related]

  • 13. Two-Year Outcomes After Exclusive Enteral Nutrition Induction Are Superior to Corticosteroids in Pediatric Crohn's Disease Treated Early with Thiopurines.
    Grover Z, Lewindon P.
    Dig Dis Sci; 2015 Oct 15; 60(10):3069-74. PubMed ID: 26038093
    [Abstract] [Full Text] [Related]

  • 14. Exclusive enteral nutrition induces early clinical, mucosal and transmural remission in paediatric Crohn's disease.
    Grover Z, Muir R, Lewindon P.
    J Gastroenterol; 2014 Apr 15; 49(4):638-45. PubMed ID: 23636735
    [Abstract] [Full Text] [Related]

  • 15. Exclusive Enteral Nutrition Therapy in Paediatric Crohn's Disease Results in Long-term Avoidance of Corticosteroids: Results of a Propensity-score Matched Cohort Analysis.
    Connors J, Basseri S, Grant A, Giffin N, Mahdi G, Noble A, Rashid M, Otley A, Van Limbergen J.
    J Crohns Colitis; 2017 Sep 01; 11(9):1063-1070. PubMed ID: 28575325
    [Abstract] [Full Text] [Related]

  • 16. Protocol for a multinational risk-stratified randomised controlled trial in paediatric Crohn's disease: methotrexate versus azathioprine or adalimumab for maintaining remission in patients at low or high risk for aggressive disease course.
    Harris RE, Aloi M, de Ridder L, Croft NM, Koletzko S, Levine A, Turner D, Veereman G, Neyt M, Bigot L, Ruemmele FM, Russell RK, PIBD SETQuality consortium and PIBDnet.
    BMJ Open; 2020 Jul 01; 10(7):e034892. PubMed ID: 32611737
    [Abstract] [Full Text] [Related]

  • 17. Crohn's Disease Exclusion Diet Plus Partial Enteral Nutrition Induces Sustained Remission in a Randomized Controlled Trial.
    Levine A, Wine E, Assa A, Sigall Boneh R, Shaoul R, Kori M, Cohen S, Peleg S, Shamaly H, On A, Millman P, Abramas L, Ziv-Baran T, Grant S, Abitbol G, Dunn KA, Bielawski JP, Van Limbergen J.
    Gastroenterology; 2019 Aug 01; 157(2):440-450.e8. PubMed ID: 31170412
    [Abstract] [Full Text] [Related]

  • 18. Exclusive enteral nutrition versus corticosteroids for treatment of pediatric Crohn's disease: a meta-analysis.
    Yu Y, Chen KC, Chen J.
    World J Pediatr; 2019 Feb 01; 15(1):26-36. PubMed ID: 30666565
    [Abstract] [Full Text] [Related]

  • 19. Predictors of Response to Exclusive Enteral Nutrition in Newly Diagnosed Crohn´s Disease in Children: PRESENCE Study from SEGHNP.
    Moriczi M, Pujol-Muncunill G, Martín-Masot R, Jiménez Treviño S, Segarra Cantón O, Ochoa Sangrador C, Peña Quintana L, González Santana D, Rodríguez Martínez A, Rosell Camps A, Armas H, Barrio J, González de Caldas R, Rodríguez Salas M, Balmaseda Serrano E, Donat Aliaga E, Bodas Pinedo A, Vaquero Sosa E, Vecino López R, Solar Boga A, Moreno Álvarez A, Sánchez Sánchez C, Tolín Hernani M, Gutiérrez Junquera C, Martinón Torres N, Leis Trabazo MR, Eizaguirre FJ, García Peris M, Medina Benítez E, Fernández Caamaño B, Vegas Álvarez AM, Crespo Valderrábano L, Alonso Vicente C, Rubio Santiago J, Galera-Martínez R, García-Romero R, Ros Arnal I, Fernández Cebrián S, Lorenzo Garrido H, Viada Bris JF, Velasco Rodríguez-Belvis M, Bartolomé Porro JM, Blanco Rodríguez M, Barros García P, Botija G, Chicano Marín FJ, La Orden Izquierdo E, Crehuá-Gaudiza E, Navas-López VM, Martín-de-Carpi J.
    Nutrients; 2020 Apr 07; 12(4):. PubMed ID: 32272604
    [Abstract] [Full Text] [Related]

  • 20. Azathioprine Plus Exclusive Enteral Nutrition Versus Azathioprine Monotherapy for the Prevention of Postoperative Recurrence in Patients with Crohn's Disease: An Open-Label, Single-Centre, Randomized Controlled Trial.
    Duan M, Lu M, Diao Y, Cao L, Wu Q, Liu Y, Gong J, Zhu W, Li Y.
    J Crohns Colitis; 2024 Aug 06; 18(7):1113-1121. PubMed ID: 38253914
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.